Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
50
Frequently Asked Questions
What is Market Cap of Avalyn Pharma Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Avalyn Pharma Inc. market cap is $1.09B.
What is the 52-week high for Avalyn Pharma Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Avalyn Pharma Inc. 52 week high is $30.20 as of May 01, 2026.
What is the 52-week low for Avalyn Pharma Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Avalyn Pharma Inc. 52 week low is $18.00 as of May 01, 2026.
What is Avalyn Pharma Inc. stock price today?
Avalyn Pharma Inc. stock price today is $28.29.
What was Avalyn Pharma Inc. stock price yesterday?
Avalyn Pharma Inc. stock price yesterday was $29.49.
What is the 50-day moving average of Avalyn Pharma Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Avalyn Pharma Inc. 50-day moving average is $23.75.